[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Biomarker (Medicine) Market Report 2017

January 2017 | 115 pages | ID: U15C164B7E4EN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Notes:

Sales, means the sales volume of Biomarker (Medicine)

Revenue, means the sales value of Biomarker (Medicine)

This report studies sales (consumption) of Biomarker (Medicine) in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
  • Roche
  • Dako (Agilent Technologies)
  • Merck
  • BD
  • Abbott
  • Genesys Biolabs
  • 20/20Genesystems
  • Affymetrix
  • Agendia
  • Almac
  • Arrayit
  • Biocartic
  • Bg Medicine
  • Kegg Expression Database
  • Thermo Fisher
  • BGI
Market Segment by States, covering
  • California
  • Texas
  • New York
  • Florida
  • Illinois
Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
  • Safety Biomarker
  • Validation Biomarker
  • Efficacy Biomarker
Split by applications, this report focuses on sales, market share and growth rate of Biomarker (Medicine) in each application, can be divided into
  • Oncology
  • Cardiology
  • Neurology
  • Others
United States Biomarker (Medicine) Market Report 2017

1 BIOMARKER (MEDICINE) OVERVIEW

1.1 Product Overview and Scope of Biomarker (Medicine)
1.2 Classification of Biomarker (Medicine)
  1.2.1 Safety Biomarker
  1.2.2 Validation Biomarker
  1.2.3 Efficacy Biomarker
1.3 Application of Biomarker (Medicine)
  1.3.1 Oncology
  1.3.2 Cardiology
  1.3.3 Neurology
  1.3.4 Others
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Biomarker (Medicine) (2012-2022)
  1.4.1 United States Biomarker (Medicine) Sales and Growth Rate (2012-2022)
  1.4.2 United States Biomarker (Medicine) Revenue and Growth Rate (2012-2022)

2 UNITED STATES BIOMARKER (MEDICINE) COMPETITION BY MANUFACTURERS

2.1 United States Biomarker (Medicine) Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Biomarker (Medicine) Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Biomarker (Medicine) Average Price by Manufactures (2015 and 2016)
2.4 Biomarker (Medicine) Market Competitive Situation and Trends
  2.4.1 Biomarker (Medicine) Market Concentration Rate
  2.4.2 Biomarker (Medicine) Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES BIOMARKER (MEDICINE) SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2012-2017)

3.1 United States Biomarker (Medicine) Sales and Market Share by States (2012-2017)
3.2 United States Biomarker (Medicine) Revenue and Market Share by States (2012-2017)
3.3 United States Biomarker (Medicine) Price by States (2012-2017)

4 UNITED STATES BIOMARKER (MEDICINE) SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2012-2017)

4.1 United States Biomarker (Medicine) Sales and Market Share by Type (2012-2017)
4.2 United States Biomarker (Medicine) Revenue and Market Share by Type (2012-2017)
4.3 United States Biomarker (Medicine) Price by Type (2012-2017)
4.4 United States Biomarker (Medicine) Sales Growth Rate by Type (2012-2017)

5 UNITED STATES BIOMARKER (MEDICINE) SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Biomarker (Medicine) Sales and Market Share by Application (2012-2017)
5.2 United States Biomarker (Medicine) Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES BIOMARKER (MEDICINE) MANUFACTURERS PROFILES/ANALYSIS

6.1 Roche
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Biomarker (Medicine) Product Type, Application and Specification
    6.1.2.1 Safety Biomarker
    6.1.2.2 Validation Biomarker
  6.1.3 Roche Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Dako (Agilent Technologies)
  6.2.2 Biomarker (Medicine) Product Type, Application and Specification
    6.2.2.1 Safety Biomarker
    6.2.2.2 Validation Biomarker
  6.2.3 Dako (Agilent Technologies) Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Merck
  6.3.2 Biomarker (Medicine) Product Type, Application and Specification
    6.3.2.1 Safety Biomarker
    6.3.2.2 Validation Biomarker
  6.3.3 Merck Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 BD
  6.4.2 Biomarker (Medicine) Product Type, Application and Specification
    6.4.2.1 Safety Biomarker
    6.4.2.2 Validation Biomarker
  6.4.3 BD Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Abbott
  6.5.2 Biomarker (Medicine) Product Type, Application and Specification
    6.5.2.1 Safety Biomarker
    6.5.2.2 Validation Biomarker
  6.5.3 Abbott Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Genesys Biolabs
  6.6.2 Biomarker (Medicine) Product Type, Application and Specification
    6.6.2.1 Safety Biomarker
    6.6.2.2 Validation Biomarker
  6.6.3 Genesys Biolabs Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 20/20Genesystems
  6.7.2 Biomarker (Medicine) Product Type, Application and Specification
    6.7.2.1 Safety Biomarker
    6.7.2.2 Validation Biomarker
  6.7.3 20/20Genesystems Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Affymetrix
  6.8.2 Biomarker (Medicine) Product Type, Application and Specification
    6.8.2.1 Safety Biomarker
    6.8.2.2 Validation Biomarker
  6.8.3 Affymetrix Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Agendia
  6.9.2 Biomarker (Medicine) Product Type, Application and Specification
    6.9.2.1 Safety Biomarker
    6.9.2.2 Validation Biomarker
  6.9.3 Agendia Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Almac
  6.10.2 Biomarker (Medicine) Product Type, Application and Specification
    6.10.2.1 Safety Biomarker
    6.10.2.2 Validation Biomarker
  6.10.3 Almac Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 Arrayit
6.12 Biocartic
6.13 Bg Medicine
6.14 Kegg Expression Database
6.15 Thermo Fisher
6.16 BGI

7 BIOMARKER (MEDICINE) MANUFACTURING COST ANALYSIS

7.1 Biomarker (Medicine) Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biomarker (Medicine)

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Biomarker (Medicine) Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biomarker (Medicine) Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES BIOMARKER (MEDICINE) MARKET FORECAST (2017-2022)

11.1 United States Biomarker (Medicine) Sales, Revenue Forecast (2017-2022)
11.2 United States Biomarker (Medicine) Sales Forecast by Type (2017-2022)
11.3 United States Biomarker (Medicine) Sales Forecast by Application (2017-2022)
11.4 Biomarker (Medicine) Price Forecast (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Picture of Biomarker (Medicine)
Table Classification of Biomarker (Medicine)
Figure United States Sales Market Share of Biomarker (Medicine) by Type in 2015
Figure Safety Biomarker Picture
Figure Validation Biomarker Picture
Figure Efficacy Biomarker Picture
Table Application of Biomarker (Medicine)
Figure United States Sales Market Share of Biomarker (Medicine) by Application in 2015
Figure Oncology Examples
Figure Cardiology Examples
Figure Neurology Examples
Figure Others Examples
Figure United States Biomarker (Medicine) Sales and Growth Rate (2012-2022)
Figure United States Biomarker (Medicine) Revenue and Growth Rate (2012-2022)
Table United States Biomarker (Medicine) Sales of Key Manufacturers (2015 and 2016)
Table United States Biomarker (Medicine) Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Biomarker (Medicine) Sales Share by Manufacturers
Figure 2016 Biomarker (Medicine) Sales Share by Manufacturers
Table United States Biomarker (Medicine) Revenue by Manufacturers (2015 and 2016)
Table United States Biomarker (Medicine) Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Biomarker (Medicine) Revenue Share by Manufacturers
Table 2016 United States Biomarker (Medicine) Revenue Share by Manufacturers
Table United States Market Biomarker (Medicine) Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Biomarker (Medicine) Average Price of Key Manufacturers in 2015
Figure Biomarker (Medicine) Market Share of Top 3 Manufacturers
Figure Biomarker (Medicine) Market Share of Top 5 Manufacturers
Table United States Biomarker (Medicine) Sales by States (2012-2017)
Table United States Biomarker (Medicine) Sales Share by States (2012-2017)
Figure United States Biomarker (Medicine) Sales Market Share by States in 2015
Table United States Biomarker (Medicine) Revenue and Market Share by States (2012-2017)
Table United States Biomarker (Medicine) Revenue Share by States (2012-2017)
Figure Revenue Market Share of Biomarker (Medicine) by States (2012-2017)
Table United States Biomarker (Medicine) Price by States (2012-2017)
Table United States Biomarker (Medicine) Sales by Type (2012-2017)
Table United States Biomarker (Medicine) Sales Share by Type (2012-2017)
Figure United States Biomarker (Medicine) Sales Market Share by Type in 2015
Table United States Biomarker (Medicine) Revenue and Market Share by Type (2012-2017)
Table United States Biomarker (Medicine) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biomarker (Medicine) by Type (2012-2017)
Table United States Biomarker (Medicine) Price by Type (2012-2017)
Figure United States Biomarker (Medicine) Sales Growth Rate by Type (2012-2017)
Table United States Biomarker (Medicine) Sales by Application (2012-2017)
Table United States Biomarker (Medicine) Sales Market Share by Application (2012-2017)
Figure United States Biomarker (Medicine) Sales Market Share by Application in 2015
Table United States Biomarker (Medicine) Sales Growth Rate by Application (2012-2017)
Figure United States Biomarker (Medicine) Sales Growth Rate by Application (2012-2017)
Table Roche Basic Information List
Table Roche Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche Biomarker (Medicine) Sales Market Share (2012-2017)
Table Dako (Agilent Technologies) Basic Information List
Table Dako (Agilent Technologies) Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Dako (Agilent Technologies) Biomarker (Medicine) Sales Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Merck Biomarker (Medicine) Sales Market Share (2012-2017)
Table BD Basic Information List
Table BD Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
Table BD Biomarker (Medicine) Sales Market Share (2012-2017)
Table Abbott Basic Information List
Table Abbott Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Abbott Biomarker (Medicine) Sales Market Share (2012-2017)
Table Genesys Biolabs Basic Information List
Table Genesys Biolabs Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Genesys Biolabs Biomarker (Medicine) Sales Market Share (2012-2017)
Table 20/20Genesystems Basic Information List
Table 20/20Genesystems Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
Table 20/20Genesystems Biomarker (Medicine) Sales Market Share (2012-2017)
Table Affymetrix Basic Information List
Table Affymetrix Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Affymetrix Biomarker (Medicine) Sales Market Share (2012-2017)
Table Agendia Basic Information List
Table Agendia Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Agendia Biomarker (Medicine) Sales Market Share (2012-2017)
Table Almac Basic Information List
Table Almac Biomarker (Medicine) Sales, Revenue, Price and Gross Margin (2012-2017)
Table Almac Biomarker (Medicine) Sales Market Share (2012-2017)
Table Arrayit Basic Information List
Table Biocartic Basic Information List
Table Bg Medicine Basic Information List
Table Kegg Expression Database Basic Information List
Table Thermo Fisher Basic Information List
Table BGI Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biomarker (Medicine)
Figure Manufacturing Process Analysis of Biomarker (Medicine)
Figure Biomarker (Medicine) Industrial Chain Analysis
Table Raw Materials Sources of Biomarker (Medicine) Major Manufacturers in 2015
Table Major Buyers of Biomarker (Medicine)
Table Distributors/Traders List
Figure United States Biomarker (Medicine) Production and Growth Rate Forecast (2017-2022)
Figure United States Biomarker (Medicine) Revenue and Growth Rate Forecast (2017-2022)
Table United States Biomarker (Medicine) Production Forecast by Type (2017-2022)
Table United States Biomarker (Medicine) Consumption Forecast by Application (2017-2022)
Table United States Biomarker (Medicine) Sales Forecast by States (2017-2022)
Table United States Biomarker (Medicine) Sales Share Forecast by States (2017-2022)


More Publications